1. Name and Address of Reporting Person*
11682 EL CAMINO REAL, SUITE 320 | |
(Street)
| 2. Issuer Name and Ticker or Trading Symbol Mirati Therapeutics, Inc. [ MRTX ] | 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) | Director | X | 10% Owner | | Officer (give title below) | | Other (specify below) | |
|
3. Date of Earliest Transaction (Month/Day/Year) 10/03/2017 |
4. If Amendment, Date of Original Filed (Month/Day/Year)
| 6. Individual or Joint/Group Filing (Check Applicable Line) | Form filed by One Reporting Person | X | Form filed by More than One Reporting Person |
|
1. Name and Address of Reporting Person*
11682 EL CAMINO REAL, SUITE 320 | |
(Street)
|
1. Name and Address of Reporting Person*
CAY HOUSE, EP TAYLOR DRIVE | |
(Street)LYFORD CAY, NEW PROVIDENCE | C5 | N7776 |
|
1. Name and Address of Reporting Person*
C/O CAY HOUSE P.O. BOX N-7776 | E.P. TAYLOR DRIVE LYFORD CAY |
(Street)
|
1. Name and Address of Reporting Person*
11682 EL CAMINO REAL, SUITE 320 | |
(Street)
|
1. Name and Address of Reporting Person*
4660 LA JOLLA VILLAGE DRIVE, SUITE 500 | |
(Street)
|
1. Name and Address of Reporting Person*
11682 EL CAMINO REAL, SUITE 320 | |
(Street)
|
1. Name and Address of Reporting Person*
11682 EL CAMINO REAL, SUITE 320 | |
(Street)
|
1. Name and Address of Reporting Person*Dissanayake Shehan Bharatha |
11682 EL CAMINO REAL, SUITE 320 | |
(Street)
|
1. Name and Address of Reporting Person*
11682 EL CAMINO REAL, SUITE 320 | |
(Street)
|
1. Name and Address of Reporting Person*
11682 EL CAMINO REAL, SUITE 320 | |
(Street)
|
| Boxer Capital, LLC, By: /s/ Aaron I Davis, Aaron I. Davis | 10/03/2017 |
| MVA Investors, LLC, By: /s/ Aaron I. Davis, Aaron I. Davis | 10/03/2017 |
| Braslyn Ltd., By: /s/ Jason Callender, Jason Callender | 10/03/2017 |
| Joseph C. Lewis, By: /s/ Joseph C. Lewis, Joseph C. Lewis | 10/03/2017 |
| Christopher Fuglesang, By: /s/ Christopher Fuglesang, Christopher Fuglesang | 10/03/2017 |
| Rodney W. Lappe, By: /s/ Rodney W. Lappe, Rodney W. Lappe | 10/03/2017 |
| Ivan M. Lieberburg, By: /s/ Ivan M. Lieberburg, Ivan M. Lieberburg | 10/03/2017 |
| Neil Reisman, By: /s/ Neil Reisman, Neil Reisman | 10/03/2017 |
| Shehan B. Dissanayake, By: /s/ Shehan B. Dissanayake, Shehan B. Dissanayake | 10/03/2017 |
| Aaron I. Davis, By: /s/ Aaron I. Davis, Aaron I. Davis | 10/03/2017 |
| ** Signature of Reporting Person | Date |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. |
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v). |
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. |
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. |